Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older

NCT04537208 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

441

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 (Healthy Volunteers)

Interventions

BIOLOGICAL: CoV2 preS dTM-AF03 (low-dose)
BIOLOGICAL: CoV2 preS dTM-AF03 (high-dose)
BIOLOGICAL: CoV2 preS dTM-AS03 (low-dose)
BIOLOGICAL: CoV2 preS dTM-AS03 (high-dose)
BIOLOGICAL: CoV2 preS dTM (high-dose) without adjuvant
BIOLOGICAL: Placebo (0.9% normal saline)

Sponsor

Sanofi Pasteur, a Sanofi Company

Collaborators

[object Object]